[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

10X Genomics Inc (TXG)

10X Genomics Inc (TXG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,006,318
  • Shares Outstanding, K 126,956
  • Annual Sales, $ 642,820 K
  • Annual Income, $ -43,540 K
  • EBIT $ -39 M
  • EBITDA $ 5 M
  • 60-Month Beta 2.05
  • Price/Sales 4.87
  • Price/Cash Flow N/A
  • Price/Book 3.60

Options Overview Details

View History
  • Implied Volatility 61.62% (-2.43%)
  • Historical Volatility 63.44%
  • IV Percentile 1%
  • IV Rank 17.08%
  • IV High 112.74% on 11/19/25
  • IV Low 51.09% on 08/21/25
  • Expected Move (DTE 23) 3.27 (13.82%)
  • Put/Call Vol Ratio 0.10
  • Today's Volume 217
  • Volume Avg (30-Day) 378
  • Put/Call OI Ratio 0.35
  • Today's Open Interest 5,768
  • Open Int (30-Day) 9,062
  • Expected Range 20.41 to 26.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-0.24
  • Number of Estimates 7
  • High Estimate $-0.18
  • Low Estimate $-0.30
  • Prior Year $0.28
  • Growth Rate Est. (year over year) -185.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
19.53 +21.25%
on 04/29/26
25.23 -6.14%
on 05/22/26
+0.85 (+3.72%)
since 04/22/26
3-Month
15.90 +48.93%
on 03/16/26
26.44 -10.46%
on 04/17/26
+4.80 (+25.42%)
since 02/20/26
52-Week
8.06 +193.61%
on 05/23/25
26.44 -10.46%
on 04/17/26
+15.14 (+177.28%)
since 05/22/25

Most Recent Stories

More News
The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call

The 5 Most Interesting Analyst Questions From 10x Genomics’s Q1 Earnings Call

TXG : 23.68 (-4.05%)
1 Cash-Producing Stock on Our Watchlist and 2 We Question

1 Cash-Producing Stock on Our Watchlist and 2 We Question

TXG : 23.68 (-4.05%)
ETSY : 62.38 (+2.70%)
TILE : 28.81 (-1.10%)
10x Genomics Q1 Earnings Call Highlights

10x Genomics (NASDAQ:TXG) reported a first-quarter revenue increase excluding prior-year settlement revenue and used its earnings call to emphasize the launch of Atera, a new spatial biology instrument...

TXG : 23.68 (-4.05%)
Why 10x Genomics (TXG) Stock Is Down Today

Why 10x Genomics (TXG) Stock Is Down Today

TXG : 23.68 (-4.05%)
TXG Q1 Deep Dive: Atara Launch, Spatial Platform Transition, and AI-Driven Demand

TXG Q1 Deep Dive: Atara Launch, Spatial Platform Transition, and AI-Driven Demand

TXG : 23.68 (-4.05%)
10x Genomics: Q1 Earnings Snapshot

10x Genomics: Q1 Earnings Snapshot

TXG : 23.68 (-4.05%)
10x Genomics’s (NASDAQ:TXG) Q1 CY2026: Beats On Revenue But Stock Drops

10x Genomics’s (NASDAQ:TXG) Q1 CY2026: Beats On Revenue But Stock Drops

TXG : 23.68 (-4.05%)
TXG's Profit Timeline Keeps Stretching While Analysts Pretend Revenue Growth Still Matters

Barchart Research What to Expect from TXG Earnings TXG Generated May 6, 2026 Current Price $22.74 EPS Estimate $$-0.27 Consensus Rating Moderate Buy Average Move 5.49% TXG's Profit Timeline Keeps Stretching...

TXG : 23.68 (-4.05%)
10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

10x Genomics (TXG) Reports Earnings Tomorrow: What To Expect

TXG : 23.68 (-4.05%)
10x Genomics to Participate in the BofA Securities 2026 Healthcare Conference

PLEASANTON, Calif. , April 29, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, announced today that members of its management team will participate...

TXG : 23.68 (-4.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

10x Genomics Inc. is a life science technology company. It develops and sells instruments, consumables and software for analyzing biological systems. 10x Genomics Inc. is based in Pleasanton, California.

See More

Key Turning Points

3rd Resistance Point 26.59
2nd Resistance Point 25.91
1st Resistance Point 24.80
Last Price 23.68
1st Support Level 23.00
2nd Support Level 22.32
3rd Support Level 21.20

See More

52-Week High 26.44
Last Price 23.68
Fibonacci 61.8% 19.42
Fibonacci 50% 17.25
Fibonacci 38.2% 15.09
52-Week Low 8.06

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.